Home
Regenesance is developing a line of products based on proprietary monoclonal antibodies to inhibit formation of the Membrane Attack Complex (MAC) part of the complement pathway. Regenesance is focused on developing treatments for the orphan drug indicatio
Life science, biotechnology, Amsterdam, Netherlands, AMC, University of Amsterdam, spin-out, spin-off, drug development, complement, inhibitor, membrane attack complex, MAC complex, C6 protein, C8 protein, C9 protein, peripheral neuropathy, peripheral ner
Is this your site? Certify your site and update informations
